Alan Berger, M.D., MPH

Alan Berger (berge063@umn.edu) is an Associate Professor of Medicine in the Cardiovascular Division. He is the Director of the Lillehei Clinical Research Unit and the director of the Cardiovascular Informatics at the University of Minnesota. Having obtained his M.D degree at the Jefferson Medical College, he completed his residency at Boston University Medical Center. His cardiovascular fellowship at Georgetown University, and his interventional cardiology fellowship at Yale University. He trained in cardiovascular outcomes research while at Georgetown University and Yale University, and completed his coursework for an M.P.H in Epidemiology while at the University Of Minnesota. His current research interests focuses on the outcomes of elderly patients with acute myocardial infarction. Alan Berger is currently dedicating his research time to the development and management of the cardiovascular informatics program. A dedicated team of individuals including a project manager, data architect. A senior level programmer, and a meta-data analyst ensure the success of the program. The data architecture is based on the fairview electronic medical record system (EPIC) and incorporates data from various cardiovascular systems (legacy and new database projects). The scope of the database include both the inpatient and ambulatory settings and spans the various cardiovascular subspecialties.

Several representative publications from Dr. Berger's studies include:

  • Newell MC, Henry JT, Henry TD, Duval S, Browning JA, Cristtiansen EC, Larson DM, Berger AK. Impact of age on treatment and outcomes in ST-elevation myocardial infarction. Am Heart J. 161:664-672.

  • Berger AK, Duval S, Jacobs DR Jr., Berber C, Vazquez G, Lee S, Luepker RV. Relation of Length of Hospital Stay in Acute Myocardial Infarction to Postdischarge mortality. Am J Cardiol.101:428-434.

  • Berger AK, Duval SJ, Armstrong C, Jacobs DR Jr, Luepker RV. Contemporary Diagnosis and Management of Hypercholesterolemia in Elderly Acute-Myocardial-Infarction Patients: A Population-based Study. Am J Geriatr Cardiol.16:15-23.

  • Berger AK, Duval S, Krumholz HM. Aspirin, Beta-blocker and Angiotensin-converting Enzyme Inhibitor Therapy in Patients with End-stage Renal Disease and an Acute Myocardial Infarction. JACC.42:201-208.

Research projects available within the cardiovascular informatics program include the following:

  • To explore outcome of patients with specific cardiovascular diseases

  • To investigate quality of care rendered to inpatients with specific cardiovascular diseases

  • To investigate relationship between patients with specific cardiovascular diseases and external data (i.e genomics, socioeconomic status, etc)